Is SpringWorks Therapeutics Inc’s (NASDAQ:SWTX) Stock Expensive Or Cheap At $59.88?

In recent trading session, SpringWorks Therapeutics Inc (NASDAQ:SWTX) saw 2.14 million shares changing hands at last check today with its beta currently measuring 0.86. Company’s recent per share price level of $59.88 trading at $4.15 or 7.45% at last check today assigns it a market valuation of $4.45B. That most recent trading price of SWTX’s stock is at a discount of -0.2% from its 52-week high price of $60.00 and is indicating a premium of 52.89% from its 52-week low price of $28.21.

For SpringWorks Therapeutics Inc (SWTX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.12. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.7 in the current quarter.

SpringWorks Therapeutics Inc (NASDAQ:SWTX) trade information

Upright in the green today for gaining 7.45%, in the last five days SWTX remained trading in the green while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $59.88 price level, adding 3.42% to its value on the day. SpringWorks Therapeutics Inc’s shares saw a change of 65.73% in year-to-date performance and have moved 1.01% in past 5-day. SpringWorks Therapeutics Inc (NASDAQ:SWTX) showed a performance of 64.73% in past 30-days.

Wall Street analysts have assigned a consensus price target of 78 to the stock, which implies a rise of 23.23% to its recent value today. Analysts have been projecting 78 as a low price target for the stock while placing it at a high target of 78. It follows that stock’s current price would drop -30.26% in reaching the projected high whereas dropping to the targeted low would mean a loss of -30.26% for stock’s current value.

SpringWorks Therapeutics Inc (SWTX) estimates and forecasts

This year revenue growth is estimated to rise 80.82% from the last financial year’s standing.

4 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 65.79M for the same. And 4 analysts are in estimates of company making revenue of 76.97M in the next quarter. Company posted 21.01M and 59.73M of sales in current and next quarters respectively a year earlier. Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -65.72% during past 5 years.

SpringWorks Therapeutics Inc (NASDAQ:SWTX)’s Major holders

FMR LLC is the top institutional holder at SWTX for having 11.11 million shares of worth $418.6 million. And as of 2024-06-30, it was holding 15.0638 of the company’s outstanding shares.

The second largest institutional holder is VANGUARD GROUP INC, which was holding about 6.54 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.8715 of outstanding shares, having a total worth of $246.53 million.

On the other hand, Fidelity Growth Company Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024, the former fund manager was holding 3.56 shares of worth $213.71 million or 4.79% of the total outstanding shares. The later fund manager was in possession of 2.1 shares on Sep 30, 2024, making its stake of worth around $125.85 million in the company or a holder of 2.82% of company’s stock.